Genomic, proteomic and other studies of the molecular basis of disease are providing a constant stream of biomolecular targets for drug discovery. Identifying suitable drugs candidates to affect these targets centres around procuring a suitable library of compounds for screening. This application addresses some of thje key issues related to the development of appropriate compound libraries for such screening programs.
|Effective start/end date||6/12/05 → 31/12/08|
- Australian Research Council (ARC): AUD225,000.00
- Iliad Chemicals Pty Ltd: AUD105,000.00